Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2022-06-06 00:00:00 ET · period of report 2022-06-02 · accession 0001209191-22-034624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-06 | 2022-06-02 | TVRD | VOGELBAUM MARTIN | Dir | A - Grant | $0.00 | +35.6K | 43.9K | +430% | $0 |
| D | 2022-06-06 | 2022-06-02 | TVRD | VOGELBAUM MARTIN | Dir | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-02 | A | A | 11,876 | $0.00 | 55,788 | D | — | — | (F2) Represents a one-time grant of 11,876 RSUs. Each RSU represents the contingent right to receive one share of the common stock of the Issuer. The RSUs are fully vested on the date of grant. |
| 2 | Common | Common Stock | 2022-06-02 | A | A | 23,752 | $0.00 | 43,912 | D | — | — | (F1) Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-06-02 | A | A | 33,993 | $0.00 | 33,993 | D | $8.42 · — to 2032-06-02 | 33,993 Common Stock | (F3) This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. |